Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 35A77 | IM / LA |
Increased sweating and increased urination frequency that did not start until day 3 and continued through today (Day 7.) He denies fever of loss of blood sugar control and not high at the moment but most recent A1C, 3 months ago, was 9.2 mg/dl. Advised to call primary care provider as symptoms could also be due to UTI, especially with SGLT2 inhibitor and average blood sugar 217 based on most recent A1c. Increased urination and sweating from high blood sugar, which he denies, can also cause increased urination and sweating. He was advised that we would fill out VAERS to document symptoms, but that they were likely due to another cause. Patient also said no redness, warmth or irritation around injection site that might be signs of cellulitis. He called PCP after we spoke and reported symptoms message to her staff.
No acute illness noted.
Type 2 diabetic on an SGLT inhibitor which can cause UTI's with increased sugar being excreted (also had skin infection in April.) He also has hyperlipidemia and eczema,
empagliflozin, rosuvastatin, aspirin 81 mg chewable, triamcinolone (KENALOG) 0.1 % cream as needed and using OTC ibuprofen and acetaminophen as need for pain/fever.
no drug or food allergies per patient on vaccine administration record although medical chart indicates lansoprazole causes rash and peanuts cause itching.
None yet. Has primary care appointment today, 6/24/25, that was already scheduled.